Reconstitution dissolves a lyophilized reference peptide in a measured volume of diluent to produce a stock solution of known concentration in mg/mL. Divide the peptide mass by the diluent volume. That number is the output.
This protocol covers bench sample preparation of a lyophilized reference standard for in-vitro assay work. It ends at a documented mg/mL stock concentration and goes no further. Nothing here describes any use outside a laboratory.
What follows is the full sequence: materials, the mass-to-volume calculation, the addition technique, controlled dissolution, a visual verification check, and labelling. Work through it once and you have a stock a colleague can reproduce from your notebook alone.
What reconstitution means for a lyophilized reference standard
Reconstitution dissolves a freeze-dried peptide solid back into a liquid diluent. The output is a stock solution of defined, recorded concentration. Lyophilization removed the solvent; reconstitution puts a measured volume back.
Lyophilization freezes the material and removes solvent by sublimation under vacuum. What remains is a dry cake or a loose powder at the bottom of the vial. That solid form ships and stores far more stably than a solution, which is why reference peptides arrive dry.
The goal of reconstitution is not "wet peptide." The goal is a defined, documented mg/mL concentration you can cite in a lab notebook and reproduce lot to lot. Two vials of the same lot, reconstituted to the same figure, should behave identically in the same assay.
One caveat sits upstream of the arithmetic. A vial's printed mass may be gross powder mass, including counter-ions such as TFA or acetate plus residual water. The peptide fraction can be materially lower — see why net peptide content differs from gross mass. Each component of that gross mass has its own determination: the peptide fraction by amino acid analysis under USP General Chapter ⟨1052⟩, the water fraction by Karl Fischer titration under USP ⟨921⟩.
When the concentration must be exact, calculate from net peptide content rather than the label. How to read a certificate of analysis shows where that figure sits on the document.
Materials and workspace
You need six things: the vial, a diluent, a calibrated volumetric transfer device, a clean work surface, labels, and a notebook or LIMS record. Every item on the list belongs to bench sample preparation.
- The lyophilized vial. Record the labelled peptide mass in mg, the compound name, and the lot number before the vial is opened.
- The diluent. The choice is a real decision with downstream consequences — see choosing between bacteriostatic and sterile water for lab prep. This protocol names the choice; that note resolves it.
- A calibrated micropipette sized for the target volume, with sterile filter tips. Deliver 2 mL as two passes of a 1,000 µL pipette rather than one over-range aspiration.
- A clean bench or laminar-flow hood, plus 70% isopropanol or ethanol wipes for the vial septum.
- Cryovials or amber tubes for aliquots, and solvent-resistant labels that survive freezing.
- A notebook or LIMS entry open before you start, not filled in afterwards from memory.
Add one optional step that prevents a common error. A vial held at −20 °C carries condensation risk the moment it is opened. Leave it sealed at 20–25 °C for 15–30 minutes so it equilibrates before the septum is broken.
Aseptic technique at the bench
Aseptic technique here protects sample integrity, nothing else. The objective is a stock free of the microbial growth and particulates that would confound an in-vitro assay.
- Wipe the septum with 70% isopropanol and allow roughly 30 seconds for it to dry.
- Never let a pipette tip contact a non-sterile surface before it enters the vial.
- Keep the vial closed except during the transfer itself.
- Work in one continuous pass rather than returning to an open vial repeatedly.
Step 1: Calculate the stock concentration in mg/mL
Stock concentration (mg/mL) = peptide mass (mg) ÷ diluent volume (mL). That single relationship is the whole calculation. Everything after this section is technique that protects the number.
Fix the equivalences once so cross-references are unambiguous: 1 mg/mL = 1,000 µg/mL = 1 g/L.
Solving for the volume to add
When the peptide mass is fixed and you have chosen a target concentration, rearrange for volume:
volume to add (mL) = peptide mass (mg) ÷ target concentration (mg/mL)
A vial labelled 10 mg with a target of 5 mg/mL requires 10 ÷ 5 = 2 mL of diluent. A vial labelled 5 mg with a target of 2 mg/mL requires 5 ÷ 2 = 2.5 mL.
Deliver the entire calculated volume in one controlled pass. Topping up by eye afterwards breaks the mass-to-volume relationship you just calculated, and the recorded concentration becomes fiction.
Solving for the concentration you will get
When the diluent volume is fixed instead, run the relationship forward. 10 mg ÷ 1 mL = 10 mg/mL. 10 mg ÷ 5 mL = 2 mg/mL. The same mass gives a fivefold concentration difference purely through volume.
| Peptide mass (mg) | Diluent volume (mL) | Resulting stock concentration (mg/mL) |
|---|---|---|
| 10 | 1.0 | 10 |
| 10 | 2.0 | 5 |
| 10 | 5.0 | 2 |
| 5 | 2.5 | 2 |
| 2 | 2.0 | 1 |
Every figure in that table is a laboratory stock concentration for in-vitro work, calculated as mg ÷ mL. None of them is anything else.
Expressing the stock as a molar concentration
Assay design usually wants molarity rather than mass concentration. The conversion is straightforward bench chemistry:
molarity (mol/L) = concentration (g/L) ÷ molecular weight (g/mol)
Worked against a real reference standard: BPC-157 has an average molecular weight of 1419.5 g/mol. A 5 mg/mL stock is 5 g/L, so 5 ÷ 1419.5 = 0.00352 mol/L, or 3.52 mM. From there a 10 µM assay point is a dilution problem, not a preparation problem.
Confirm the molecular weight against the lot's COA or PubChem before you record any molar figure — the BPC-157 entry used above is CID 9941957. Salt forms and counter-ions shift the mass, and a molarity calculated from the wrong molecular weight is wrong by that ratio. A trifluoroacetate counter-ion adds about 114 per basic site, so the free-peptide molecular weight and the salt's gross molecular weight are not the same number.
Step 2: Add the diluent slowly down the vial wall
Angle the vial and let the measured diluent run down the inner glass wall over several seconds. Never jet it directly into the lyophilized cake.
The reason is mechanical. A high-velocity stream and the foam it generates create shear and a large air-liquid interface. Peptides adsorb and unfold at that interface, and unfolded chains aggregate. Aggregated material has left solution, so the concentration you calculated no longer describes what is in the vial.
Deliver the full calculated volume in a single pass, then record the volume you actually delivered rather than the volume you intended. The difference matters more than it looks: 10 mg in 1.95 mL is 5.13 mg/mL, not 5.00 mg/mL. A 2.5% volume error is a 2.6% concentration error carried into every dilution downstream.
Keep the vial upright once the full volume is in. Do not swirl yet — the cake needs time to wet before any agitation.
Step 3: Dissolve gently — do not vortex or shake
Let the vial stand for 5–10 minutes so the diluent wets the cake. Then dissolve with a slow swirl, or by rolling the vial between your palms. Do not vortex, do not shake vigorously, and do not reach for sonication by default.
Vigorous agitation foams the solution, and foam is the same air-liquid interface described in Step 2 with far more surface area. For fragile sequences that is the fastest route to aggregation, and aggregation silently lowers the concentration in solution below the figure in your notebook.
When dissolution is slow, escalate time rather than force. Extend standing time in 15-minute increments up to roughly an hour at 20–25 °C, swirling gently between intervals. For heat-sensitive sequences, hold at 2–8 °C and allow longer instead of warming the vial.
If the solid still resists after that, the problem is solubility chemistry, not technique. Solubility is a property of the sequence: Sarma and colleagues in the Journal of Physical Chemistry B show peptide solubility limits tracking backbone and side-chain interactions rather than any bench variable you control, and a 2023 Analytical Chemistry study works through the practical difficulty of getting hydrophobic peptides into solution without acid-catalyzing their degradation. Some sequences require a trace co-solvent selected against their charge character — see choosing a solvent for a hard-to-dissolve peptide. Do not improvise solvent chemistry at the bench.
Step 4: Verify complete dissolution
Hold the vial against a light background and confirm the solution is clear and free of visible particulates or residual cake. Until the solid is fully in solution, the calculated mg/mL is not the real concentration.
Some sequences give a faint opalescence even when fully dissolved. Record what you observe rather than deciding on the spot that it is acceptable. Persistent cloudiness, floating particulates, visible fibrils, or a gel all indicate incomplete dissolution or a solubility mismatch.
Be clear about what this check is. It is a visual bench check on sample integrity — nothing more. It says nothing about identity or purity, which come from the analytical record on the lot's certificate of analysis. A perfectly clear solution of the wrong compound looks exactly like a perfectly clear solution of the right one.
Write down three fields at this point: appearance, elapsed time to full dissolution, and the temperature it dissolved at.
Step 5: Label, aliquot, and record
Label every tube with six fields, split the stock into single-use aliquots, and write the full calculation into the notebook. An unlabelled stock is an unusable stock within a week.
Label fields, all six, on every tube:
- Compound name
- Lot number
- Stock concentration in mg/mL
- Diluent
- Date reconstituted
- Preparer initials
Aliquot to the size of one experiment. Repeated freeze-thaw cycling degrades peptides in solution, so the bulk stock should never be thawed twice. This is a characterized effect, not lab folklore: Jain and colleagues, writing in Scientific Reports, set out a freeze-thaw characterization workflow specifically to minimize cycle-driven aggregation in protein solutions. For assay work, 50–200 µL aliquots are typical, and a 2 mL stock at 5 mg/mL splits into ten 200 µL aliquots. Each holds 1 mg of peptide: 200 µL × 5 mg/mL = 1 mg, and 10 × 200 µL = 2 mL.
Record the full derivation, not just the answer: peptide mass, volume delivered, resulting mg/mL, diluent and its lot, date, and initials. Add the molar concentration when you calculated one. That entry is what makes the stock reproducible by someone who was not at the bench.
Finally, note that reconstituted stability is a different question from lyophilized stability, with different numbers. Hold the working aliquot at 2–8 °C and freeze the rest — the specifics belong to lyophilized vs reconstituted peptide storage and shelf life.
The protocol in five steps
The whole procedure compresses into five checkpoints. If any checkpoint fails, stop there rather than carrying an unknown concentration forward.
| Step | Action | Checkpoint |
|---|---|---|
| 1 | Calculate mass ÷ volume → mg/mL | Target concentration written down before the vial is opened |
| 2 | Add the full calculated volume down the inner wall | Delivered volume recorded, no foam |
| 3 | Stand 5–10 min, then swirl or roll | Dissolved without vortexing or shaking |
| 4 | Inspect against a light background | Clear, no particulates or residual cake |
| 5 | Label six fields, aliquot single-use, record | Notebook entry reproducible by a colleague |
That is the complete arc. A lyophilized reference standard becomes a defined mg/mL stock: mass ÷ volume, added gently, dissolved without agitation, verified by eye, labelled.
For the diluent decision, start with bacteriostatic versus sterile water. For what happens after the stock exists, see storage and shelf life. If the label on your vial is doing work the paperwork should be doing, read what "reference-grade" means on a peptide label. Every BPC-157 reference standard we ship carries the lot-level COA those calculations depend on.
Frequently asked questions
What does it mean to reconstitute a lyophilized peptide?
Reconstitution dissolves a freeze-dried peptide powder back into a liquid diluent, forming a stock solution of known mg/mL concentration for in-vitro research. Lyophilization removed the solvent under vacuum for stable shipping and storage. Reconstitution returns a measured volume, so the dry cake becomes a defined, documented stock you can reproduce.
How do you calculate a peptide stock concentration in mg/mL?
Divide the peptide mass by the diluent volume: stock concentration (mg/mL) = peptide mass (mg) ÷ diluent volume (mL). To hit a target concentration instead, rearrange it: volume to add (mL) = peptide mass (mg) ÷ target concentration (mg/mL). A 10 mg vial with 2 mL of diluent gives a 5 mg/mL stock, because 10 ÷ 2 = 5.
How much diluent do you add to a 10 mg peptide vial?
It depends entirely on the stock concentration you want. For 5 mg/mL add 2 mL, because 10 ÷ 5 = 2. For 2 mg/mL add 5 mL; for 10 mg/mL add 1 mL. The mass-to-volume ratio sets the concentration, so choose the volume from your target and record what you actually delivered.
Why add the diluent slowly down the side of the vial?
Running diluent down the inner glass wall, rather than jetting it onto the lyophilized cake, minimizes foaming and shear stress. Foam creates a large air-liquid interface where peptide chains adsorb and unfold, which promotes aggregation. Aggregated material leaves solution, so the stock ends up below the mg/mL figure your calculation predicted.
Should you vortex a peptide to dissolve it faster?
No. Vigorous vortexing or shaking foams the solution and can promote aggregation of sensitive sequences. Dissolve with a slow swirl, or by rolling the vial between your palms. Allow extra standing time when dissolution is slow — 15-minute increments at 20–25 °C, up to roughly an hour. Escalate time, never mechanical force.
How do you know a reconstituted peptide is fully dissolved?
A correctly reconstituted stock is typically clear and free of visible particulates or undissolved cake when held against a light background. Cloudiness, particulates, fibrils, or a gel indicate incomplete dissolution or a solubility mismatch. Until the solid is fully in solution, do not rely on the calculated mg/mL — and record the appearance you observed.
elev8 Labs products are reference standards for laboratory research only. Not for human consumption.